173 related articles for article (PubMed ID: 31067275)
1. The chromatin structuring protein HMGA2 influences human subtelomere stability and cancer chemosensitivity.
Ahmed SM; Ramani PD; Wong SQR; Zhao X; Ivanyi-Nagy R; Leong TC; Chua C; Li Z; Hentze H; Tan IB; Yan J; DasGupta R; Dröge P
PLoS One; 2019; 14(5):e0215696. PubMed ID: 31067275
[TBL] [Abstract][Full Text] [Related]
2. Oncofetal HMGA2 attenuates genotoxic damage induced by topoisomerase II target compounds through the regulation of local DNA topology.
Ahmed SM; Dröge P
Mol Oncol; 2019 Oct; 13(10):2062-2078. PubMed ID: 31271486
[TBL] [Abstract][Full Text] [Related]
3. Chaperoning HMGA2 protein protects stalled replication forks in stem and cancer cells.
Yu H; Lim HH; Tjokro NO; Sathiyanathan P; Natarajan S; Chew TW; Klonisch T; Goodman SD; Surana U; Dröge P
Cell Rep; 2014 Feb; 6(4):684-97. PubMed ID: 24508460
[TBL] [Abstract][Full Text] [Related]
4. Oncofetal HMGA2 effectively curbs unconstrained (+) and (-) DNA supercoiling.
Zhao X; Peter S; Dröge P; Yan J
Sci Rep; 2017 Aug; 7(1):8440. PubMed ID: 28814752
[TBL] [Abstract][Full Text] [Related]
5. Chromatin Architectural Factors as Safeguards against Excessive Supercoiling during DNA Replication.
Ahmed SM; Dröge P
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599919
[TBL] [Abstract][Full Text] [Related]
6. High Mobility Group A2 protects cancer cells against telomere dysfunction.
Natarajan S; Begum F; Gim J; Wark L; Henderson D; Davie JR; Hombach-Klonisch S; Klonisch T
Oncotarget; 2016 Mar; 7(11):12761-82. PubMed ID: 26799419
[TBL] [Abstract][Full Text] [Related]
7. Nanoscale Assembly of High-Mobility Group AT-Hook 2 Protein with DNA Replication Fork.
Krahn N; Meier M; To V; Booy EP; McEleney K; O'Neil JD; McKenna SA; Patel TR; Stetefeld J
Biophys J; 2017 Dec; 113(12):2609-2620. PubMed ID: 29262356
[TBL] [Abstract][Full Text] [Related]
8. Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I.
Peter S; Yu H; Ivanyi-Nagy R; Dröge P
Nucleic Acids Res; 2016 Dec; 44(22):e162. PubMed ID: 27587582
[TBL] [Abstract][Full Text] [Related]
9. Reversible Top1 cleavage complexes are stabilized strand-specifically at the ribosomal replication fork barrier and contribute to ribosomal DNA stability.
Krawczyk C; Dion V; Schär P; Fritsch O
Nucleic Acids Res; 2014 Apr; 42(8):4985-95. PubMed ID: 24574527
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
11. The FGFR inhibitor PD173074 binds to the C-terminus of oncofetal HMGA2 and modulates its DNA-binding and transcriptional activation functions.
Ahmed SM; Ragunathan P; Shin J; Peter S; Kleissle S; Neuenschwander M; Schäfer R; Kries JPV; Grüber G; Dröge P
FEBS Lett; 2023 Aug; 597(15):1977-1988. PubMed ID: 37259564
[TBL] [Abstract][Full Text] [Related]
12. High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation.
Boo LM; Lin HH; Chung V; Zhou B; Louie SG; O'Reilly MA; Yen Y; Ann DK
Cancer Res; 2005 Aug; 65(15):6622-30. PubMed ID: 16061642
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer.
Huang YM; Cheng CH; Pan SL; Yang PM; Lin DY; Lee KH
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684108
[TBL] [Abstract][Full Text] [Related]
14. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
Kaur H; Hütt-Cabezas M; Weingart MF; Xu J; Kuwahara Y; Erdreich-Epstein A; Weissman BE; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2015 Feb; 74(2):177-85. PubMed ID: 25575139
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy.
Summer H; Li O; Bao Q; Zhan L; Peter S; Sathiyanathan P; Henderson D; Klonisch T; Goodman SD; Dröge P
Nucleic Acids Res; 2009 Jul; 37(13):4371-84. PubMed ID: 19465398
[TBL] [Abstract][Full Text] [Related]
16. siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.
Esmailzadeh S; Mansoori B; Mohammadi A; Shanehbandi D; Baradaran B
J Gastrointest Cancer; 2017 Jun; 48(2):156-163. PubMed ID: 27629422
[TBL] [Abstract][Full Text] [Related]
17. Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability.
Husain A; Begum NA; Taniguchi T; Taniguchi H; Kobayashi M; Honjo T
Nat Commun; 2016 Feb; 7():10549. PubMed ID: 26842758
[TBL] [Abstract][Full Text] [Related]
18. Hmga2 protein loss alters nuclear envelope and 3D chromatin structure.
Divisato G; Chiariello AM; Esposito A; Zoppoli P; Zambelli F; Elia MA; Pesole G; Incarnato D; Passaro F; Piscitelli S; Oliviero S; Nicodemi M; Parisi S; Russo T
BMC Biol; 2022 Aug; 20(1):171. PubMed ID: 35918713
[TBL] [Abstract][Full Text] [Related]
19. Oncological role of HMGA2 (Review).
Zhang S; Mo Q; Wang X
Int J Oncol; 2019 Oct; 55(4):775-788. PubMed ID: 31432151
[TBL] [Abstract][Full Text] [Related]
20. A crucial role of a high mobility group protein HMGA2 in cardiogenesis.
Monzen K; Ito Y; Naito AT; Kasai H; Hiroi Y; Hayashi D; Shiojima I; Yamazaki T; Miyazono K; Asashima M; Nagai R; Komuro I
Nat Cell Biol; 2008 May; 10(5):567-74. PubMed ID: 18425117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
